DataMeds AI, Inc. filed a Form S-1 registration statement for an initial public offering on 2024-07-22. It has amended it 10 times. It filed its final prospectus on 2025-09-29, at a public offering price of $0.70 per share. Each fact below is quoted from the filing named with it.
What the filings say
Listing
Our common stock is listed on the Nasdaq under the symbol “MEDS”.From the S-1 filed 2026-08-07
Shares offered
We are offering 7,142,862 shares of Common Stock, together with Warrants to purchase up to 7,142,862 shares of Common Stock.From the 424B4 filed 2025-09-29
Offering price
7,142,862 shares of Common Stock, at a public offering price of $0.70 per share.From the 424B4 filed 2025-09-29
Use of proceeds
We intend to use the net proceeds from this offering for working capital and general corporate purposes, which may include operating expenses, research and development, and pending and future acquisitions.From the 424B4 filed 2025-09-29
Revenue
(ii) the last day of the fiscal year in which we have total annual gross revenues of $1.07 billion or more;From the S-1 filed 2026-08-07
Net loss or income
The Company has a net loss of $517,599 for the year ended December 31,2023 and members’ deficit of $531,149 as of December 31, 2023.From the S-1 filed 2025-05-05
Timeline
| Filed | What it is | Filing |
|---|---|---|
| 2024-07-22 | Registration statement filed | S-1 |
| 2024-08-02 | Registration statement amended | S-1/A |
| 2024-09-27 | Registration statement amended | S-1/A |
| 2024-10-21 | Registration statement amended | S-1/A |
| 2024-11-06 | Registration statement amended | S-1/A |
| 2024-12-06 | Registration statement amended | S-1/A |
| 2024-12-18 | Registration statement amended | S-1/A |
| 2025-01-14 | Registration statement amended | S-1/A |
| 2025-02-21 | Final prospectus filed: the offering is priced | 424B4 |
| 2025-05-05 | Registration statement filed | S-1 |
| 2025-07-24 | Registration statement filed | S-1 |
| 2025-08-29 | Registration statement amended | S-1/A |
| 2025-09-12 | Registration statement amended | S-1/A |
| 2025-09-22 | Registration statement amended | S-1/A |
| 2025-09-29 | Final prospectus filed: the offering is priced | 424B4 |
| 2026-08-07 | Registration statement filed | S-1 |
Tools for this story
Each opens in a new tab, filled in for DataMeds AI, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A company that wants to sell shares to the public in the United States files a registration statement with the SEC: Form S-1 for a US company, Form F-1 for a foreign one. It amends that statement as the figures and terms are filled in, usually adding the expected price range shortly before the offering. Once the offering is priced it files its final prospectus under Rule 424(b)(4). A company that decides not to go ahead can ask for the registration statement to be withdrawn on Form RW.
Every row on this page is one of those filings, linked to the filing itself. The facts are the company's own sentences, quoted from the filing named beside each one and never reworded; where no filing states a fact in a sentence that can be read exactly, this page leaves it out. A filing is the company's statement of its plans and its figures, not a verification of them, and nothing here is investment advice.